Successful 271-Day Pig Kidney Xenotransplant Marks Milestone in Organ Replacement Research

The ongoing global organ shortage crisis affects over 100,000 individuals in the U.S. alone, with many awaiting kidney transplants.

• Record achievement: A genetically modified pig kidney functioned for 271 days in a human patient, Tim Andrews, marking a significant milestone in xenotransplantation.
• Successful transition: After nearly nine months of dialysis-free survival, Andrews received a human kidney transplant that continues to function effectively.
• Research implications: This case highlights the potential of xenotransplantation as a bridge to human organ transplants, addressing critical shortages.

• Critical shortage: Over 100,000 people in the U.S. are on the waiting list for organ transplants, with kidneys being the most sought-after.
• Previous attempts: Earlier xenotransplantation efforts had limited success, with the first pig-to-human kidney transplant in 2024 lasting only 52 days.
• Genetic modification: The pig kidney used in this case was genetically edited to reduce rejection risks, showcasing advancements in biotechnology.

The recent success of Tim Andrews' pig kidney transplant at Massachusetts General Hospital represents a pivotal moment in the field of xenotransplantation. This procedure, which took place on January 25, 2025, utilized a genetically modified Yucatan miniature pig kidney provided by eGenesis. The organ functioned immediately, allowing Andrews to avoid dialysis for an impressive 271 days. This achievement is particularly significant given the ongoing organ shortage crisis, which has left many patients in dire need of transplants.

The procedure's success can be attributed to advancements in genetic engineering, specifically the use of CRISPR technology to modify pig organs. These modifications aim to reduce the risk of organ rejection, a major hurdle in xenotransplantation. The early rejection episode experienced by Andrews was managed effectively, demonstrating the potential for medical teams to navigate challenges associated with xenotransplantation.

Following the pig kidney's removal in October 2025, Andrews returned to dialysis for approximately 82 days before receiving a compatible human kidney transplant in January 2026. This transition marks the first documented case of a successful bridge from porcine to human kidney transplantation, paving the way for future research and clinical applications.

Medical researchers, including lead author Dr. Leonardo Riella, emphasize that xenotransplantation could serve as both a bridge to human organ transplants and a potential destination therapy for patients with end-stage organ failure. The implications of this research extend beyond individual cases, as it could influence policies and practices surrounding organ donation and transplantation globally.

As the medical community continues to explore the long-term safety and durability of pig organs, the findings from this case will likely prompt further investigations and discussions about the ethical and practical aspects of xenotransplantation. The potential to alleviate the organ shortage crisis through innovative solutions like xenotransplantation could reshape the landscape of organ donation and transplantation in the coming years.

• Patients with kidney disease: Those awaiting transplants may benefit from increased availability of xenotransplanted organs.
• Healthcare providers: Hospitals and transplant centers may see shifts in protocols and practices related to organ transplantation.
• Biotechnology firms: Companies involved in genetic engineering and organ transplantation may experience growth and investment opportunities.

• Clinical trials: Ongoing studies into the long-term safety and efficacy of xenotransplantation will be crucial for future applications.
• Policy changes: Watch for potential shifts in organ donation policies as xenotransplantation gains traction in medical practice.
• Public perception: The acceptance of xenotransplantation by patients and the general public will influence its integration into healthcare systems.